HSG

Cloudphysician is a prominent provider of Smart-ICU services that utilizes a cloud-based platform to enhance critical care delivery. The company employs advanced technologies, including artificial intelligence, the Internet of Things, and predictive analytics, to facilitate real-time clinical decision-making and improve patient outcomes. By offering remote management solutions, Cloudphysician enables healthcare providers to monitor patients effectively, assisting in early-stage diagnosis of critical illnesses in adults and tracking the health and immunization of newborns to reduce neonatal mortality rates. Through this innovative approach, Cloudphysician aims to transform the healthcare landscape, providing hospitals and healthcare professionals with improved support and training capabilities.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Neurowyzr is a company focused on enhancing brain health through a comprehensive healthcare platform. It specializes in the detection, diagnosis, therapy, monitoring, and prevention of brain decline. By offering a range of evidence-based tools, Neurowyzr empowers healthcare providers to promote awareness and facilitate positive changes in brain health. The company's approach emphasizes early intervention and the prevention of cognitive decline, aiming to shift societal perspectives on brain health and encourage proactive maintenance of cognitive well-being.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

HealiRNA develops infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They provide mRNA drug research and development, production, clinical trial design, and data analysis services.

hoop is India’s first wellness brand for an active lifestyle! hoop’s wellness range is the answer India needs – effective pain, sleep, stress, workout products crafted with natural ingredients that feel amazing to use.

FitBudd is a software as a service (SaaS) platform based in Gurgaon, Haryana, that supports health and fitness coaches in growing their businesses on a global scale. The platform provides an all-in-one trainer portal that enables fitness professionals to manage their clients effectively, create tailored training and nutrition plans, and track client progress. By enhancing client engagement and retention, FitBudd helps instructors offer personalized fitness sessions while promoting a healthy lifestyle. Its solutions are designed to make fitness coaches more accessible to a worldwide audience, thereby facilitating business expansion for fitness professionals.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

NuProbe, Inc. is a genomics and molecular diagnostics company that specializes in noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative polymerase chain reaction (qPCR) mutation detection. The company's innovative probe technology facilitates a Sample-In Answer-Out (SIAO) solution, integrating cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretations. This precision diagnostic technology is designed for the early detection of cancer and infectious diseases, offering high sensitivity and the ability to capture disease signatures comprehensively. As a result, healthcare specialists are empowered to act swiftly, enabling timely treatment for patients.

Us2.ai is a Singapore-based company that specializes in developing software and digital tools for echocardiography using artificial intelligence. The company's platform automates the manual process of measuring and interpreting echocardiograms, which are ultrasound images of the heart. This automation provides decision support tools designed to save doctors time, improve clinical trials for pharmaceutical companies, and enhance the detection of hard-to-diagnose cardiovascular conditions in hospitals. Us2.ai aims to simplify access to results of echo analysis and heart ultrasound through its online solutions.

the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

SyMap Medical is focused on the development and manufacturing of innovative medical devices aimed at treating hypertension and related diseases, including heart failure, arrhythmia, and severe asthma. The company specializes in a proprietary catheter-based renal mapping and ablation system that utilizes radiofrequency (RF) ablation technology. This system is designed for renal denervation therapy, which involves mapping and selectively ablating renal nerves to effectively manage hypertension. Through its advanced technology platform, SyMap Medical aims to address significant health challenges associated with major cardiovascular and respiratory conditions.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Edge Medical Robotics, Inc. is a Shenzhen, China-based company that specializes in the design and development of advanced surgical equipment. Founded on May 4, 2017, the company is dedicated to researching and promoting cutting-edge smart technologies aimed at enhancing surgical safety and treatment efficacy. By focusing on the pursuit of excellence and refinement in its products, Edge Medical Robotics seeks to elevate health standards and improve overall social health outcomes.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Metware is a developer of advanced medical metabolic technology, focusing on metabolomics to enhance life science research and clinical applications. The company specializes in metabolism analysis and testing services, targeting areas such as cancer, metabolic disorders, and infectious diseases. By leveraging innovative metabolism technology, Metware aims to provide effective data analysis that supports patients and facilitates improved treatment options in the medical field.

Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

Analytical Biosciences is a developer of single-cell genomics focused on creating precise maps of human diseases. The company collaborates with medical research institutions, hospitals, and pharmaceutical firms to leverage single-cell genomics and bioinformatics for improving disease diagnosis and treatment. By conducting large-scale systematic mapping of diseases at the single-cell level, Analytical Biosciences engages in extensive data mining to support its partners in discovering new therapeutic targets and developing innovative treatment strategies. Utilizing high-resolution databases and advanced data analytics, the company aims to unlock disease mechanisms and facilitate the identification and validation of novel cellular targets and biomarkers. This approach positions Analytical Biosciences at the forefront of advancing next-generation therapeutics and diagnostics.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed through collaboration with Tsinghua University, Neuracle focuses on innovative research in neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs and other tools that allow healthcare institutions to monitor patients' brain bioelectricity levels and accurately diagnose neural conditions. Neuracle's research and development efforts have garnered acceptance from experts in both neuroscience and clinical medicine, positioning the company as a leader in its field and a key contributor to national science and technology initiatives.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

NuProbe, Inc. is a genomics and molecular diagnostics company that specializes in noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative polymerase chain reaction (qPCR) mutation detection. The company's innovative probe technology facilitates a Sample-In Answer-Out (SIAO) solution, integrating cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretations. This precision diagnostic technology is designed for the early detection of cancer and infectious diseases, offering high sensitivity and the ability to capture disease signatures comprehensively. As a result, healthcare specialists are empowered to act swiftly, enabling timely treatment for patients.

Virta Health Corp. is an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company utilizes a combination of nutritional biochemistry, clinical expertise, and data science to develop innovative treatments. Through its continuous remote care platform, Virta provides medical and behavioral support that enables patients to achieve significant health improvements, including lower blood sugar levels and weight loss. Clinical trials have shown that 60% of enrolled patients achieved diabetes reversal within one year, while 94% of insulin users were able to reduce or eliminate their insulin use. Additionally, the benefits of Virta's treatment extend to metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

SiBionics is a medtech company headquartered in Shenzhen, China, focused on the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. The company specializes in innovative solutions for medical imaging and neuromodulation, striving to create cost-effective products that enhance long-term health monitoring and disease management. SiBionics is developing various advanced technologies, including implanted retinal electrical stimulators, continuous glucose monitoring systems, and screening tools for gastric cancer and chronic diseases. Through the integration of visual coding, artificial intelligence, and medical big data, SiBionics aims to address critical health issues such as retinitis pigmentosa, diabetes, cardiovascular and cerebrovascular diseases, and gastrointestinal tumors, ultimately improving diagnostic and treatment options for these conditions.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Yaoyanshe, established in 2012 and headquartered in Shanghai, China, operates as a Contract Research Organization (CRO) technology platform. It specializes in providing end-to-end services for pharmaceutical research and development, including clinical monitoring, project management, registration affairs, biostatistics, pharmacovigilance, medical affairs, and Site Management Organization (SMO) services. The company's core offering is an application designed to facilitate value sharing and trading within the industry, empowering patients with up-to-date treatment information and enabling professionals to assess creditworthiness, analyze competition, and evaluate sponsor projects more effectively. Yaoyanshe aims to address key industry challenges and enhance the efficiency of pharmaceutical research and development.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, using both tissue and liquid biopsy samples. Its principal products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency. Burning Rock collaborates with major pharmaceutical companies for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. The company, founded in 2014, is headquartered in Guangzhou, China, with a focus on providing individualized cancer treatment guidance using medical and bioinformatics technologies.

VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Beijing Deep Intelligent Pharma Technology Co., Ltd. specializes in leveraging artificial intelligence and blockchain technology to enhance drug discovery, development, and medical affairs for pharmaceutical companies. Founded in 2017 and based in Beijing, the company offers a range of products, including a multi-language medical machine translation engine, intelligent pharmacovigilance for risk management, and tools for creating multilingual educational materials. Deep Intelligent Pharma also provides AI-enabled solutions for medical writing, document review, and quality control, as well as a patient search ecosystem to facilitate medical and clinical research. Additionally, the company offers intelligent regulatory affairs solutions to streamline drug research and development processes. Operating globally, including in China, the United States, and Japan, Deep Intelligent Pharma aims to improve the efficiency and quality of the pharmaceutical development lifecycle.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

NuProbe, Inc. is a genomics and molecular diagnostics company that specializes in noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative polymerase chain reaction (qPCR) mutation detection. The company's innovative probe technology facilitates a Sample-In Answer-Out (SIAO) solution, integrating cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretations. This precision diagnostic technology is designed for the early detection of cancer and infectious diseases, offering high sensitivity and the ability to capture disease signatures comprehensively. As a result, healthcare specialists are empowered to act swiftly, enabling timely treatment for patients.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.

Suburban Diagnostics is a provider of comprehensive diagnostic and pathology services, operating multiple centers across Maharashtra. The company specializes in delivering precise diagnostics and accurate reporting, with a focus on pathology, radiology, and cardiology. In addition to its diagnostic services, Suburban Diagnostics offers health check-up programs, aiming to enhance the quality of care for patients and support healthcare providers in their treatment efforts. Through its commitment to accuracy and comprehensive service offerings, Suburban Diagnostics plays a crucial role in the healthcare landscape.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, using both tissue and liquid biopsy samples. Its principal products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency. Burning Rock collaborates with major pharmaceutical companies for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. The company, founded in 2014, is headquartered in Guangzhou, China, with a focus on providing individualized cancer treatment guidance using medical and bioinformatics technologies.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

Health 724 is a health service provider based on users, health managers, and health products. They offer direct supply of health products to users who are concerned about their own and their families' health, as well as customized health solutions.

Orasis Pharmaceuticals Ltd is a pharmaceutical company based in Herzliya, Israel, founded in 2015. The company specializes in the development of corrective eye drops aimed at treating presbyopia, a common age-related vision condition. Its primary product, CSF-1, is designed to improve near visual acuity through pupil modulation, thereby alleviating the need for reading glasses. By repurposing existing, well-studied molecules, CSF-1 aims to provide an effective, safe, and easy-to-use solution that enhances the quality of life for individuals affected by presbyopia. This noninvasive treatment option offers patients a practical alternative for managing their near vision difficulties.

Dongri Zhongyi Guan is a chain organisation for TCM diagnosis and treatment that integrates Internet technologies with the fundamental principles of traditional TCM. Pediatric illnesses, andrological illnesses such as impotence, early ejaculation, prostate, etc., spleen and stomach illnesses, colds and flu, neck and lumbar illnesses, liver and gallbladder illnesses, and other illnesses are all treated by them.

SyMap Medical is focused on the development and manufacturing of innovative medical devices aimed at treating hypertension and related diseases, including heart failure, arrhythmia, and severe asthma. The company specializes in a proprietary catheter-based renal mapping and ablation system that utilizes radiofrequency (RF) ablation technology. This system is designed for renal denervation therapy, which involves mapping and selectively ablating renal nerves to effectively manage hypertension. Through its advanced technology platform, SyMap Medical aims to address significant health challenges associated with major cardiovascular and respiratory conditions.

Burning Rock Biotech Limited specializes in developing and providing cancer therapy selection tests in the People's Republic of China. The company offers a range of next-generation sequencing-based tests applicable to various cancer types, using both tissue and liquid biopsy samples. Its principal products include OncoScreen Plus for therapy and immunotherapy guidance, LungPlasma for non-small cell lung cancer, ColonCore for gastrointestinal cancers, and HRDCore for homologous recombination deficiency. Burning Rock collaborates with major pharmaceutical companies for clinical trials and research studies, primarily through central laboratory and companion diagnostics services. The company, founded in 2014, is headquartered in Guangzhou, China, with a focus on providing individualized cancer treatment guidance using medical and bioinformatics technologies.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Angel Group Holding Company, founded in 2008 and based in Chengdu, China, focuses on integrating high-quality medical resources and managing healthcare brands. The company employs a development strategy centered on scale, branding, and professionalism, gradually expanding its services and investments into various interventional medical fields. Notably, its flagship facility, Angel Maternity Hospital, has garnered recognition as a leading maternity hospital in China, receiving awards for its reputation and quality of care. This hospital is distinguished as the first in China and the only one in the southwest region to achieve accreditation from the Joint Commission International. Angel Group is committed to a comprehensive approach that encompasses medical treatment, research, prevention, care, and rehabilitation, while maintaining a modern management structure and a skilled team of physicians. The company aims to adhere to international standards in healthcare management, continually seeking to enhance its operations and expand its presence within the mainland Chinese healthcare market.

In China, almost every doctor must face overloaded with work. The number of patients they received a day or even a week,the number of foreign doctors will be reception. In addition to China's large population of natural conditions, the unity of the health care system, pattern, so difficult and tense doctor-patient relationship and other issues remain unresolved.

Cloudnine Hospitals, founded in 2007 by Dr. R. Kishore Kumar and his co-founders, is a leading healthcare provider in India specializing in maternal, gynecological, neonatal, and pediatric care. With a mission to elevate healthcare standards, Cloudnine aims to transform societal attitudes towards pregnancy, promoting the idea that it is a celebration of life rather than an illness. The organization offers a wide range of services, including support for infertility, conception, and delivery, while ensuring comprehensive medical care throughout pregnancy and beyond. Cloudnine operates over 20 facilities across major cities such as Bengaluru, Chennai, Gurgaon, Mumbai, Pune, and Chandigarh, with plans for further expansion to enhance access to quality healthcare for women and children throughout India. The hospital group is committed to maintaining international standards of care, reflecting its vision of providing world-class healthcare services.

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Suburban Diagnostics is a provider of comprehensive diagnostic and pathology services, operating multiple centers across Maharashtra. The company specializes in delivering precise diagnostics and accurate reporting, with a focus on pathology, radiology, and cardiology. In addition to its diagnostic services, Suburban Diagnostics offers health check-up programs, aiming to enhance the quality of care for patients and support healthcare providers in their treatment efforts. Through its commitment to accuracy and comprehensive service offerings, Suburban Diagnostics plays a crucial role in the healthcare landscape.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Glocal Healthcare is a company focused on transforming healthcare delivery through a technology-enabled platform that enhances accessibility and affordability, particularly in rural areas where traditional healthcare services are limited. It operates a network of hospitals that provide a range of services, including outpatient and inpatient care, emergency services, and obstetric care. Glocal also utilizes digital dispensaries and telemedicine, offering video consultations through its two applications, hellolyf and hellolyf Dr, available on Google Play. With 250 telemedicine and IoT-based digital clinics and 10 hospitals across India, Glocal Healthcare aims to ensure timely treatment and improve health outcomes for underserved populations.

Moolchand Healthcare is a prominent healthcare service provider operating multi-specialty hospitals in Delhi, India. It offers comprehensive medical care through its specialty hospitals, staffed by internationally trained physicians and equipped with state-of-the-art technology and world-class infrastructure. The company specializes in treating various life-threatening and acute physical ailments.

Hinacom Software and Technology, Ltd. is a Beijing-based healthcare IT company that specializes in medical imaging and information management solutions. Established in 2008, the company offers its flagship product, miPlatform, an integrated suite designed for the medical imaging industry. This suite encompasses various components, including Enterprise PACS/RIS for optimized workflow management, Regional PACS for collaborative imaging services across hospitals, and TeleMed/TeleRad systems for image transmission and conferencing via web platforms. Additionally, miPlatform features web-based 3D processing and mobile imaging systems. Hinacom’s solutions are utilized by hospitals and regional teleradiology projects in China, as well as by radiologists and clinicians across the United States, Europe, and Southeast Asia.

Moolchand Healthcare is a prominent healthcare service provider operating multi-specialty hospitals in Delhi, India. It offers comprehensive medical care through its specialty hospitals, staffed by internationally trained physicians and equipped with state-of-the-art technology and world-class infrastructure. The company specializes in treating various life-threatening and acute physical ailments.

Glocal Healthcare is a company focused on transforming healthcare delivery through a technology-enabled platform that enhances accessibility and affordability, particularly in rural areas where traditional healthcare services are limited. It operates a network of hospitals that provide a range of services, including outpatient and inpatient care, emergency services, and obstetric care. Glocal also utilizes digital dispensaries and telemedicine, offering video consultations through its two applications, hellolyf and hellolyf Dr, available on Google Play. With 250 telemedicine and IoT-based digital clinics and 10 hospitals across India, Glocal Healthcare aims to ensure timely treatment and improve health outcomes for underserved populations.

Attenti, formerly known as Dmatek, is a global provider of remote monitoring technologies, specializing in presence and location verification solutions for the criminal justice sector. Founded in 1990 and headquartered in Tel Aviv, Israel, with additional offices in Milwaukee, Wisconsin, Attenti develops and manufactures advanced wireless monitoring solutions aimed at enhancing safety and security. The company's offerings include systems for senior housing, such as wandering prevention, nurse call, and resident well-being monitoring solutions. Attenti's products cater to a diverse clientele, including private and public organizations, monitoring service providers, and government agencies across more than 25 countries. The company is recognized for its commitment to high-quality technology and innovation, driven by a team with extensive field experience.

Sai Life Sciences Ltd. is a contract development and manufacturing organization that specializes in discovering and developing medicines for pharmaceutical and biotechnology companies. Founded in 1999 and headquartered in Hyderabad, India, the company offers a comprehensive range of services, including synthetic and medicinal chemistry, analytical method development, preclinical and clinical formulation, and late-phase manufacturing. It also provides specialized services such as flow chemistry, particle engineering, and toxicology assessments. With additional facilities in Pune, Bidar, and representation in Tokyo, as well as labs in Cambridge and Manchester, Sai Life Sciences serves clients across India, the United States, the European Union, and Japan. The company's mission is to facilitate faster and more cost-effective drug development for its partners by delivering high-quality research and manufacturing solutions while fostering long-term collaborative relationships.